Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients-Reference-Cited by-同舟云学术

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

Published:2014-01 Issue:5 Volume:32 Page:585-591
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dhédin Nathalie,Krivine Anne,Le Corre Nicole,Mallet Alain,Lioure Bruno,Bay Jacques-Olivier,Rubio Marie-Thérèse,Agape Philippe,Thiébaut Anne,Le Goff Jérôme,Autran Brigitte,Ribaud Patricia

Funder

Institut de Microbiologie et de Maladies Infectieuses

PHRC: Programme Hospitalier de Recherche Clinique

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. Influenza B in transplant patients;Aschan;Scand J Infect Dis,1989

2. Influenza A in immunocompromised patients;Ljungman;Clin Infect Dis,1993

3. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation;Ljungman;Bone Marrow Transplant,2001

4. Influenza A virus infections among hospitalized adult bone marrow transplant recipients;Whimbey;Bone Marrow Transplant,1994

5. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy;Nichols;Clin Infect Dis,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplant;Human Vaccines & Immunotherapeutics;2024-07-08

2. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients;Blood Advances;2024-04-10

3. Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients;Clinical Infectious Diseases;2023-08-16

4. Impact de la pandémie Covid-19 sur l’activité nationale et les risques afférents à la greffe de cellules souches hématopoïétiques - Une étude rétrospective conjointe de la Société francophone de greffe de moelle et de thérapie cellulaire et de l’Agence de la biomédecine, et une revue de la littérature;Hématologie;2023-07-01

5. Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer;The Lancet Child & Adolescent Health;2023-03